While it has been well established that infants born to women who are obese show higher risks of obesity, scientists have not known how this occurs.
A new study has now shown that umbilical cells from children of obese or overweight mothers may transfer genes that are faulty in regulating cell energy and metabolism.
Researchers at Joslin Diabetes Center believe the findings may help to pave the way toward improved healthcare, both before and after birth, for children at heightened risk of obesity, says Elvira Isganaitis, M.D., M.P.H.
Isganaitis, assistant investigator and staff pediatric endocrinologist at Joslin and instructor in pediatrics at Harvard Medical School, is the corresponding author on a paper about the work published in the International Journal of Obesity.
The Joslin study also suggests that the increased risks of obesity may be driven by boosted levels of certain lipids (fats and other substances that are not soluble in water) in the maternal blood that flows through the umbilical cord, said Isganaitis.
Suzana Maria Ramos Costa, M.D., Ph.D., of Joslin and the Federal University of Pernambuco in Recife, Brazil, who is co-first author on the paper, began the research by gathering umbilical cords after birth from healthy Brazilian women without diabetes. Costa recruited 24 overweight or obese women (with a body mass index over 25 before pregnancy) and 13 women who were not overweight for the study.
The scientists collected umbilical cells from the vein that carries oxygen and other nutrients from the placenta to the embryo. “These samples give a window into the nutrients and metabolites that are coming from the mom into the infant,” said Isganaitis.
The Joslin team discovered that in these cells, increased obesity in the mothers correlated with lower expression of genes regulating mitochondria (which act as the cell’s powerhouses) and of other genes regulating the production and metabolism of lipids.
“This suggests that already at birth there are detectable metabolic perturbations resulting from maternal obesity,” she said. Changes in these cells were similar to some known to occur in obesity, insulin resistance and type II diabetes, she adds.
When the researchers followed up by analyzing fetal blood from the umbilical cord vein, “we found that the infants of obese mothers had significantly higher levels of many lipids that are known to be metabolically deleterious, like saturated fatty acids,” Isganaitis said.
Fat tissues in the obese mothers may shed fatty acids that make their way into the fetal blood and create a kind of “fuel overload” for the embryo, she said.
Isganaitis and her colleagues will now carry out further research on umbilical cells and blood among Boston newborns to see if the study results are confirmed in this population. Similar analyses will also be performed for children born to mothers who have either gestational diabetes or type I diabetes.
Additionally, Isganaitis is examining how such prenatal exposures may encourage certain stem cells found in umbilical cords, which can differentiate into various types of tissues, to preferentially turn into fat cells.
She hopes that eventually it will be possible to use blood markers to identify embryos at risk for obesity or related conditions such as type II diabetes, and to follow up with suitable medical interventions.
“Pregnant women engage often with their healthcare providers, and you can really tap into their motivation,” she said. “If we could come up with tailored interventions — if we could say, take this vitamin, exercise regularly and you can minimize obesity or diabetes risk in your child — I’m sure mothers would do it.”
Isganaitis adds that mothers and health care providers also could carefully monitor the growth patterns and nutrition of children at risk of obesity, both in the first two years of life and afterwards.
“Your risk of chronic diseases isn’t set in stone at birth; there are many different periods in which your lifelong disease risk can be modulated,” she emphasized.
Source: Joslin Diabetes Center